| 產(chǎn)品名稱 | Flibanserin - BIMT 17 |
| 產(chǎn)品貨號 | Axon 1499 CAS [167933-07-5 ] MF C20H21F3N4OMW 390.40 Purity: 99% Soluble in DMSO Description A 5-HT1A receptor full agonist with 5-HT2A receptor antagonistic activity; It was initially investigated as an potential antidepressant, however, it is currently under clinical trial for the potential treatment of female sexual dysfunction References Certificates Categories Extra info E Jolly?et al. Design of Phase III pivotal trials of flibanserin in female Hypoactive Sexual Desire Disorder (HSDD). Sexologies. 2008, 17, Supplement 1, S133-S134.? ? F Borsini?et al.?Pharmacology of flibanserin. CNS Drug Rev. 2002,?8 (2), 117–142.? Certificate of Analysis Material Safety Data Sheet CNS 5-HT1A 5-HT2A D4 A19 5-HT1A agonist and 5-HT2A antagonist Chemical name 1-[2-[4-(3-trifluoromethylphenyl)piperazin-1-yl]ethyl]benzimidazol-[1H]-2-one Parent CAS No. [167933-07-5 ] Order Size Unit Price Stock 10 mg €95.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Flibanserin - BIMT 17Axon 1499 CAS [167933-07-5 ] MF C20H21F3N4O
Description
A 5-HT1A receptor full agonist with 5-HT2A receptor antagonistic activity; It was initially investigated as an potential antidepressant, however, it is currently under clinical trial for the potential treatment of female sexual dysfunction
5-HT1A agonist and 5-HT2A antagonist
Chemical name1-[2-[4-(3-trifluoromethylphenyl)piperazin-1-yl]ethyl]benzimidazol-[1H]-2-one Parent CAS No.[167933-07-5 ] |
| 產(chǎn)品資料 |
